Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) - Concepedia

Concepedia

Publication | Closed Access

Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva)

23

Citations

28

References

2013

Year

Nissar A. Darmani, Seetha Chebolu, Weixia Zhong, Chung Trinh, Bryan McClanahan, Rajivinder Singh Brar

European Journal of Pharmacology

Cannabis UseMolecular PharmacologyPsychoactive DrugPharmacologyCannabinoid Cb1/2 ReceptorPharmacotherapyAdditive Antiemetic EfficacyCryptotis ParvaMedicineCannabinoid Pharmacology

References

	Year	Citations

Page 1